Overview
Christopher Willner is a Hematologist Oncology specialist and a Hematologist in Novi, Michigan. Dr. Willner has been practicing medicine for over 9 years and is rated as an Experienced provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Hemophagocytic Lymphohistiocytosis, Childhood Acute Myeloid Leukemia, and Bone Marrow Aspiration. Dr. Willner is currently accepting new patients.
His clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- INSURANCE PLAN
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
39450 W 12 Mile Rd, Novi, MI 48377
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Regents Of The University Of Michigan
Sami Malek is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Malek is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Follicular Lymphoma, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, and Bone Marrow Aspiration. Dr. Malek is currently accepting new patients.
Erlene Seymour is a Hematologist Oncology provider in Detroit, Michigan. Dr. Seymour is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). Her top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-Cell Lymphoma (DLBCL), and Sickle Cell Disease.
Mark Kaminski is an Oncologist and a Hematologist in Ann Arbor, Michigan. Dr. Kaminski is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Gastric Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Willner isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Experienced
- Acquired HemophiliaDr. Willner isExperienced. Learn about Acquired Hemophilia.
- Acute Myeloblastic Leukemia with Maturation
- AgranulocytosisDr. Willner isExperienced. Learn about Agranulocytosis.
- B-Cell LymphomaDr. Willner isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow AspirationDr. Willner isExperienced. Learn about Bone Marrow Aspiration.
- Burkitt LymphomaDr. Willner isExperienced. Learn about Burkitt Lymphoma.